ARTICLE | Clinical News
ALRT1057: Will launch a Phase III trial in about 150 patients
January 8, 1996 8:00 AM UTC
Allergan Ligand Retinoid Therapeutics Inc. (ALRIZ), San Diego, Calif. Product: ALRT1057, topical 9-cis-retinoic acid Indication: Kaposi's sarcoma in AIDS Status: Will launch a Phase III trial in about...